Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evity Technologies is a biotechnology company specializing in the isolation and molecular profiling of extracellular vesicles (EVs) for diagnostic and therapeutic applications. Spun out from the University of Pennsylvania, the company utilizes a proprietary microfluidic platform designed for high-throughput and high-purity recovery of EVs from complex biological samples such as blood. This technology enables the analysis of EV-associated biomarkers, facilitating the development of non-invasive liquid biopsies for early detection of cancer and neurological disorders. Beyond diagnostics, Evity Technologies' platform serves as a critical tool for the characterization and quality control of EV-based therapeutic delivery systems. The company aims to bridge the gap between EV research and clinical utility through its scalable and precise isolation hardware.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evity Technologies.